Aprogen Biologics Inc. (KRX:003060)

Aprogen Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	42,281	102,540	130,793	190,684	200,481	360,706
Market Cap Growth	-72.56%	-21.60%	-31.41%	-4.89%	-44.42%	-31.18%
Enterprise Value	289,253	318,576	176,792	383,113	209,570	302,520
Last Close Price	3210.00	7785.00	9930.00	33059.13	57340.49	103167.28
PE Ratio	-	-	-	-	15.86	44.52
PS Ratio	0.58	1.40	1.94	2.18	3.08	6.39
PB Ratio	0.15	0.37	0.35	0.52	0.39	0.60
P/TBV Ratio	0.21	0.51	0.35	0.53	0.48	0.71
P/FCF Ratio	-	-	-	-	8.20	-
P/OCF Ratio	-	-	-	-	7.79	-
EV/Sales Ratio	3.95	4.35	2.62	4.39	3.22	5.36
EV/FCF Ratio	-6.04	-	-	-	8.57	-
Debt / Equity Ratio	0.82	0.82	0.41	0.49	0.26	0.00
Debt / FCF Ratio	-	-	-	-	5.51	-
Net Debt / Equity Ratio	0.64	0.64	0.31	0.46	0.07	-0.20
Net Debt / EBITDA Ratio	-1.71	-1.71	-2.93	-3.47	-19.81	64.35
Net Debt / FCF Ratio	-3.70	-3.70	-2.50	-2.77	1.46	17.44
Asset Turnover	0.12	0.12	0.11	0.14	0.10	0.09
Inventory Turnover	1.94	1.94	1.50	1.98	1.25	3.09
Quick Ratio	0.32	0.32	0.38	0.17	0.75	15.45
Current Ratio	0.67	0.67	0.78	0.54	1.49	37.41
Return on Equity (ROE)	-51.29%	-51.29%	-28.09%	-26.24%	2.46%	1.53%
Return on Assets (ROA)	-13.04%	-13.04%	-6.20%	-6.94%	-0.40%	-0.40%
Return on Invested Capital (ROIC)	-26.88%	-25.90%	-11.33%	-13.02%	-0.75%	-0.85%
Return on Capital Employed (ROCE)	-34.30%	-34.30%	-13.20%	-16.40%	-0.80%	-0.70%
Earnings Yield	-402.86%	-166.11%	-80.26%	-62.02%	6.30%	2.25%
FCF Yield	-113.19%	-46.67%	-35.37%	-32.38%	12.19%	-1.95%
Buyback Yield / Dilution	-57.15%	-57.15%	-99.30%	-56.07%	-1.42%	-25.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.